Hazardous drinking and alcohol use disorders

J MacKillop, R Agabio, SW Feldstein Ewing… - Nature Reviews …, 2022 - nature.com
Alcohol is one of the most widely consumed psychoactive drugs globally. Hazardous
drinking, defined by quantity and frequency of consumption, is associated with acute and …

[HTML][HTML] Improving access to evidence-based medical treatment for opioid use disorder: strategies to address key barriers within the treatment system

BK Madras, NJ Ahmad, J Wen, JS Sharfstein - NAM perspectives, 2020 - ncbi.nlm.nih.gov
Even though evidence-based treatment for opioid use disorders (OUD) is effective, almost
four in five Americans with OUD do not receive any form of treatment. The gap in access to …

Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management

JV Pergolizzi Jr, RB Raffa… - Journal of clinical …, 2020 - Wiley Online Library
What is known and objective Opioid use in the United States has reached unprecedented—
some would even say crisis—levels. Although many individuals use opioid drugs as part of …

Article Commentary: Stepped Care for Opioid use Disorder Train the Trainer (SCOUTT) Initiative: Expanding Access to Medication Treatment for Opioid use Disorder …

AJ Gordon, K Drexler, EJ Hawkins, J Burden… - Substance …, 2020 - journals.sagepub.com
The US is confronted with a rise in opioid use disorder (OUD), opioid misuse, and opioid-
associated harms. Medication treatment for opioid use disorder (MOUD)—including …

[HTML][HTML] Methadone matters: what the United States can learn from the global effort to treat opioid addiction

SL Calcaterra, P Bach, A Chadi, N Chadi… - Journal of general …, 2019 - Springer
In the midst of an opioid epidemic, mortality related to opioid overdose continues to rise in
the US. Medications to treat opioid use disorder, including methadone and buprenorphine …

Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002–11

AW Dick, RL Pacula, AJ Gordon, M Sorbero… - Health …, 2015 - healthaffairs.org
Opioid use disorders are a significant public health problem, affecting two million people in
the United States. Treatment with buprenorphine, methadone, or both is predominantly …

A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees

BD Stein, AW Dick, M Sorbero, AJ Gordon… - Substance …, 2018 - journals.sagepub.com
Background: Medication treatment (MT) with methadone and buprenorphine are effective
treatments for opioid use disorders, but little information is available regarding the extent to …

Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps

JJ Wyse, AJ Gordon, SK Dobscha, BJ Morasco… - Substance …, 2018 - Taylor & Francis
Abstract The US Department of Veterans Affairs (VA), the largest health care system in the
US, has been confronted with the health care consequences of opioid disorder (OUD) …

[HTML][HTML] Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis

A Rabiee, N Mahmud, C Falker… - Hepatology …, 2023 - journals.lww.com
Background: Medications for alcohol use disorder (MAUD) are highly effective in achieving
and maintaining abstinence in patients with alcohol use disorder (AUD). Our aim was to …

[HTML][HTML] Attitudes of primary care physicians toward prescribing buprenorphine: a narrative review

DL Louie, MT Assefa, MP McGovern - BMC Family Practice, 2019 - Springer
Background The opioid epidemic is a major public health issue associated with significant
overdose deaths. Effective treatments exist, such as the medication buprenorphine, but are …